<bdo id="u6wwk"></bdo>
  • <dd id="u6wwk"><wbr id="u6wwk"></wbr></dd>

    Shanghai RASS-Safety,Quality,Efficacy

    • a1_banpc01_1.jpg 2-245.jpg
    • a1_banpc01_3-191.jpg 3.jpg
    • banner-3-1.jpg banner-3-2.jpg
    • banner-1.jpg banner-1-2.jpg
    beijing.jpg chanpinzhongxin.jpg
    a1_banpc04.jpg xinwenzhongxin.jpg
    a1_banpc05.jpg guanyulaishi.jpg

    About RAAS

    Being vital for life saving, blood products are important national strategic reserve materials. Founded in 1988 and situated at No. 2009 Wangyuan Road, Fengxian District, Shanghai with a registered capital of RMB 6,740,787,907.00, Shanghai RAAS was listed on the Shenzhen Stock Exchange in June 2008 as a leading domestic blood products company that integrates source plasma collection, blood products research and development, production and sales.

    • 35 years
      Extensive industry experience
    • 4 units
      Production Bases
    • 42 centers (including newly approved)
      Plasma Donation Center
    Yuan +0.20 (+3.13%)
    Stock Code:
    a1_banpc06.jpg laishijiangzhan.jpg

    RAAS Plasma Donation Center

    As of May 2023, Shanghai RAAS and its subsidiaries had 42 plasma donation centers (including newly approved ) in China including those under construction, of which 18 are Shanghai RAAS (including one subcenter) , 19 are Tonrol Biopharmaceutical (including newly approved) , 2 are Zhengzhou RAAS and 3 are Zhejiang Haikang Biopharmaceutical, covering 11 provinces (autonomous regions) in Guangxi, Hunan, Hainan, Shaanxi, Anhui, Guangdong, Inner Mongolia, Zhejiang, Hubei, Jiangxi and Shandong.

    • 18 centers
      Shanghai RAAS (including one subcenter)
    • 19 centers
      Tonrol Biopharmaceutical
    • 2 centers
      Zhengzhou RAAS
    • 3 centers
      Zhejiang Haikang Biopharmaceutical
    <bdo id="u6wwk"></bdo>
  • <dd id="u6wwk"><wbr id="u6wwk"></wbr></dd>